x
Ariana Pharma
[contact-form-7 404 "Not Found"]

Ariana Pharma
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News & more
    • In The News
    • Case study
    • Publications
      • Publications & Conferences
      • Whitepaper & blog
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com

Tag: recent post

Precision Medicine
Ariana Pharma - Img

May2021

Ariana appoints pharmaceutical industry drug development veteran

Prior to joining Ariana, Hichem was Director of Development Operations at Sanofi. Hichem’s significant achievements encompass multiple therapeutic areas

Read More
Autoimmune disease Precision Medicine
Ariana Pharma - Img

May2021

Ariana announces an Artificial Intelligence-driven Precision Medicine collaboration with Sanofi

The ATRACTion project will generate clinical, multi-omic (single cell RNA expression, gut microbiota) and additional immunological data by investigating several auto-immune diseases.

Read More
Precision Medicine
Ariana Pharma - Img

May2021

Ariana Announces Appointment of Accomplished Business and Strategy Executive, Kia Motesharei to its Board of Directors.

Dr. Motesharei brings over 20 years of experience in management, strategy, business development, alliance management, product development and marketing across the biotechnology and pharmaceutical industry.

Read More
Alzheimer's
Ariana Pharma - Img

Apr2020

Towards a first precision medicine treatment of Alzheimer’s disease using Ariana’s Explainable AI.

Paris and Boston, April 17th 2020. Ariana® Pharma, a leading digital health company announced today the publication of the first reported genome-wide search for biomarkers associated with drug response in Alzheimer’s disease in the Alzheimer’s & Dementia: Translational Research & Clinical Interventions journal. Using Ariana’s proprietary KEM® (Knowledge Extraction and Management) advanced Artificial Intelligence technology, […]

Read More
Real World Evidence
Ariana Pharma - Img

Nov2019

Comorbidities play an important role in hospitalized influenza mortality risk, Real World Evidence (RWE) study performed by Ariana and Sanofi Pasteur shows

Big Data analysis of over 125 Million patient hospitalization records using Ariana’s data analytics and AI platform identifies significant factors increasing Case Fatality Rates Paris and Boston, November 7th 2019. Ariana Pharma, a leading digital health Company announced the publication of an influenza Real World analysis in collaboration with Sanofi-Pasteur. Influenza-related mortality for hospitalized patients […]

Read More
Type A Diabetes
Ariana Pharma - Img

Sep2019

Towards a first precision medicine Immunotherapy for the treatment of Type 1 Diabetes using Ariana’s Artificial Intelligence

Ariana’s KEM® Artificial Intelligence technology identified immunological changes, which are early indicators of clinical effects, for selected groups of patients in a first-in-human Phase 1b study. The potential for a selection biomarker in patients receiving this therapy transforms design options for Imcyse’s future clinical trials in T1D and additional indications. On August 27th 2019, Imcyse, […]

Read More
Cancer
Ariana Pharma - Img

Mar2019

Colon Cancer and combination therapy: Ariana to present data at AACR 2019 using its AI technology and PDX mouse model simulated clinical trial

Ariana to present data at AACR 2019 on using its KEM® Artificial Intelligence technology and PDX mouse models to simulate patient stratification in clinical trials and Identify companion biomarkers for combination therapy Ariana Pharma, a leading digital health Company focused on developing advanced therapeutic decision support systems, will present its latest results on combination therapy […]

Read More
Alzheimer's

Oct2018

Ariana’s AI provides evidence for 3 years clinical efficacy of ANAVEX®2-73 Alzheimer’s targeted therapy @CTAD2018

Precision medicine approach using Ariana’s AI KEM® shows that a small data rich open label clinical study of 32 well-characterized patients may be sufficient to identify strong biomarker hypothesis identifying patients with the highest chance of benefiting from the drug.   BARCELONA, October 26th, 2018. Dr Mohammad Afshar presented 3 years longitudinal data of clinical […]

Read More
Cancer

Oct2018

Ariana Pharma helps Valiseek® demonstrate efficacy of its lung cancer therapy in phase 2 clinical trial

Ariana Pharma helps Valiseek® demonstrate efficacy of its lung cancer therapy in phase 2 clinical trial.   Ariana®’s KEM® data analysis shows positive results for ValiSeek VAL401 in Phase II trial for non-small cell lung cancer (NSCLC) patients. Ariana’s KEM® (Knowledge Extraction and Management) advanced Artificial Intelligence technology, shows that patients receiving the VAL401 treatment […]

Read More
Alzheimer's

Sep2018

Artificial Intelligence enables first biomarker driven precision medicine therapy against Alzheimer

Ariana Pharma helps ANAVEX® demonstrate efficacy of its Alzheimer’s therapy in phase 2a clinical trial. Ariana’s KEM® Artificial Intelligence technology has resulted in the identification of the first actionable genetic variant biomarkers, selecting a specified Alzheimer’s disease population, who demonstrated a confirmed response with ANAVEX®2-73. Professor Harald Hampel, M.D., Ph.D., presenting results at the AAIC […]

Read More

Posts navigation

1 2

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Oncology Professor Jean-Yves BLAY Centre Leon berard Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2024 All Rights Reserved